Neurocysticercosis: Relationship between Taenia antigen levels in CSF and MRI;Neurocisticercose: Relação entre antígeno da Taenia no líquido cefalorraquidiano e ressonância magnética

Arquivos de Neuro-Psiquiatria

Volumn 68, Issue 1, 2010, Pages 7-11

  Abraham, Ronaldo ^a   Livramento, José Antonio ^b   Leite, Cláudia da Costa ^b   Pardini, Alessandra Xavier ^b   Vaz, Adelaide José ^b   Machado, Luís dos Ramos ^b  

^a UNIVERSITY OF TAUBATÉ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Central nervous system; Cerebrospinal fluid; Enzyme linked immunosorbent assay; Magnetic resonance imaging; Neurocysticercosis; Taenia antigens detection

Indexed keywords

PARASITE ANTIGEN;

ADULT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BRAIN DAMAGE; CEREBROSPINAL FLUID EXAMINATION; CEREBROSPINAL FLUID LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPTIC STATE; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROCYSTICERCOSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; TAENIA; ANIMAL; CEREBROSPINAL FLUID; COMPARATIVE STUDY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADULT; ANIMALS; ANTIGENS, HELMINTH; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; TAENIA; YOUNG ADULT;

EID: 77950489388     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/s0004-282x2010000100003     Document Type: Article

References (32)

1. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis 2002;2:751-762.
2. Del Brutto OH. Neurocysticercosis. Sem Neurol 2005;25:243-251.
3. Garcia HH, Del Brutto OH. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005;4:653-661.
4. Román G, Sotelo J, Del Brutto OH, et al. A proposal to declare neurocysticercosis an international reportable disease. Bull World Health Organ 2000;78:399-406.
5. Schantz PM, Cruz M, Sarti E, Pawlowzki Z. Potential eradicability of taeniasis and cysticercosis. Bull PAHO 1993;27:397-403.
6. Bern C, Garcia HH, Evans C, et al. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Inf Dis 1999;29:1203-1209.
7. Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology 2004;63:1559-1564.
8. Townes JM, Hoffmann CJ, Kohn MA. Neurocysticercosis in Oregon, 1995-2000. Emerg Infect Dis 2004;10:508-510.
9. Esquivel A, Diaz-Otero F, Gimenez-Roldán S. Growing frequency of neurocysticercosis in Madrid (Spain). Neurologia 2005;20:116-120.
10. Imirizaldu L, Miranda L, Garcia-Gurtubay I, Gastón I, Urriza J, Quesada P. Neurocysticercosis: uma enfermedad emergente. An Sist Sanit Navar 2004;27:201-209.
11. Enseñat J, Martinez-Manas R, Horcajada JP, De Juan C, Ferrer E. Diagnostic and therapeutic difficulties in neurocysticercosis: presentation of 6 cases and review of the literature. Neurocirurgia (Astur) 2007;18:101-110.
12. Roca C, Gascón J, Font B, Pujol T, Valls ME, Corachán M. Neurocysticercosis and population movements: analysis of 23 imported cases in Spain. Eur J Clin Microbiol Infect Dis 2003;22:382-384.
13. Takayanagui OM, Leite JP. Neurocisticercose. Rev Soc Bras Med Trop 2001;34: 283-290.
14. Agapejev S. Epidemiology of neurocysticercosis in Brazil. Rev Inst Med Trop 1996;38:283-290.
15. Wittig EO. Neurocisticercose: formas clínicas e aspectos anátomo-patológicos. In Machado LR, Livramento JA, Spina-Franc ̧a A, Nóbrega JPS (Eds). Neuroinfecção 96; São Paulo, Clínica Neurológica HC/FMUSP; 1996:193-204.
16. White AC Jr. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 1997;24:101-115.
17. Bueno EC, Machado LR, Livramento JA, Vaz AJ. Cellular immune response of patients with neurocysticercosis (inflammatory and non-inflammatory phases). Acta Tropica 2004;91:205-213.
18. Sotelo J, Guerrero J, Rubio F. A new classification based on active and inactive forms. Arch Intern Med 1985;145:442-445.
19. Del Brutto OH, Rajshekhar V, White Jr AC, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57:177-183.
20. Garcia HH, Gonzalez AE, Gilman RH. Diagnosis, treatment and control of Taenia solium cysticercosis. Curr Op Infect Dis 2003;16:411-419.
21. Dumas JL, Visy JM, Belin C, Gaston A, Goldlust D, Dumas M. Parenchymal neurocysticercosis: follow-up and staging by MRI. Neuroradiology 1997;39:12-18.
22. Amaral LLF, Ferreira RM, Rocha AJ, Ferreira NPDF. Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms. Top Magn Reson Imaging 2005;16:127-144.
23. Lange O. Síndrome liquórico da cisticercose encéfalo meníngea. Rev Neurol Psiquiatr S Paulo 1940;6:35-48.
24. Spina-França A, Livramento JA, Machado LR. Cysticercosis of central nervous system and CSF: immunodiagnosis of 1573 patients in 63 years (1929-1992). Arq Neuropsiquiatr 1993;51:16-20.
25. Pardini AX, Vaz AJ, Machado LR, Livramento JA. Cysticercus antigens in cerebrospinal fluid samples from patients with neurocysticercosis. J Clin Microbiol 2001;39:3368-3372.
26. Ishida MM, Peralta RH, Livramento JA, Hoshino-Shimizu S, Peralta JM, Vaz AJ. Serodiagnosis of neurocysticercosis in patients with epileptic seizure using ELISA and immunoblot assay. Rev Inst Med Trop S. Paulo 2006;48:343-346.
27. Suzuki LA, Arruda GC, Quagliato EM, Rossi QL. Evaluation of Taenia solium and Taenia crassiceps cysticercal antigens for immunodiagnosis of neurocysticercosis using ELISA on CSF samples. Rev Soc Bras Med Trop 2007;40:152-155.
28. Mandal J, Singhi PD, Khandelwal N, Malla N. Evaluation of lower molecular mass (20-24 kDa) Taenia solium cysticercus antigen fraction by ELISA and dot blot for the serodiagnosis of neurocysticercosis in children. Parasitol Res 2008;102:1097-1101.
29. Abraham R, Pardini AX, Vaz AJ, Livramento JA, Machado LR. TA detection in the cerebrospinal fluid of patients with neurocysticercosis and its relationship with clinical activity of the disease. Arq Neuropsiquiatr 2004;62:756-760.
30. Fleury A, Hernández M, Fragoso G, Parkhouse RME, Harrison LJS, Sciutto E. Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis. Royal Soc Trop Med Hyg 2003;97:542-546.
31. Bobes RJ, Hernandez M, Marquez C, et al. Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up. Trop Med Int Health 2006;11:943-950.
32. Del Brutto OH, Santibañez R, Noboa CA, Aguirre R, Díaz E, Alarcón TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992;42:389-392.